subject_id=OCCAMS/PS/008;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/017;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/005;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
